# Stem Cell Injection in Cancer Survivors

> **NCT02509156** · PHASE1 · COMPLETED · sponsor: **The University of Texas Health Science Center, Houston** · enrollment: 46 (actual)

## Conditions studied

- Cardiomyopathy Due to Anthracyclines

## Interventions

- **BIOLOGICAL:** Allo-MSCs
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT02509156
- **Lead sponsor:** The University of Texas Health Science Center, Houston
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-08
- **Primary completion:** 2019-11
- **Final completion:** 2020-04-20
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2020-11-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02509156

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02509156, "Stem Cell Injection in Cancer Survivors". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02509156. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*